HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
HealthEquity Trading Up 2.8 %
NASDAQ:HQY opened at $82.20 on Friday. The stock has a market cap of $7.11 billion, a price-to-earnings ratio of 75.41, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business's 50-day simple moving average is $97.63 and its 200 day simple moving average is $96.30.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the stock. KeyCorp dropped their target price on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Monday, March 24th. Barrington Research reissued an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Finally, Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $112.58.
Get Our Latest Stock Report on HQY
Hedge Funds Weigh In On HealthEquity
Institutional investors have recently made changes to their positions in the business. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity during the fourth quarter worth approximately $26,000. Versant Capital Management Inc bought a new position in HealthEquity during the 1st quarter valued at $28,000. Transce3nd LLC bought a new stake in shares of HealthEquity in the 4th quarter worth about $29,000. Smartleaf Asset Management LLC raised its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new position in shares of HealthEquity during the fourth quarter worth about $39,000. 99.55% of the stock is owned by institutional investors and hedge funds.
HealthEquity Company Profile
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
